Explore Dual-PhD carrier research, patent-pending modified-chitosan delivery, and 4 flexible cosmetic ODM tracks.
Palmitoyl Pentapeptide-4 Firming Cream Concept
A peptide-based cream concept built around Palmitoyl Pentapeptide-4, commonly used in firming and age-support formulation projects. Suitable for internal evaluation, concept validation, and OEM/ODM development discussions.
Formulation Snapshot
Formulation Snapshot
+219% 8-hour ex-vivo skin permeation, -32.0% ACh inhibition at 1/10th dose, and GQI 33-subject trial data.
Inspect on-site booth photos, ISO 22716:2007 cosmetic GMP certificate, and buyer Q&A from Guangzhou.
Applications
Application Direction
- Firming cream
- Age-support skincare
- Peptide cream concept
- Daily care formula
Overview
Overview
This formulation concept is designed for teams evaluating peptide-based cream development. It provides a structured starting point for firming and age-support skincare projects built around Palmitoyl Pentapeptide-4.
Details
Details
Important Note: This page presents a reference formulation concept for evaluation, OEM/ODM discussion, and product development planning. It is not presented as a retail-ready finished product or a final regulatory-approved market formula.
Concept Positioning
Palmitoyl Pentapeptide-4 is commonly reviewed in skincare projects focused on firming care, age-support positioning, and cream-based active product development. This concept provides a practical reference for teams exploring peptide-based cream formats in a more structured and discussion-ready way.
Typical Product Direction
- Firming cream concepts
- Age-support skincare projects
- Daily care peptide cream development
- Premium cream positioning for OEM/ODM discussion
Why Teams Review This Concept
- Evaluate how Palmitoyl Pentapeptide-4 fits into a cream format
- Compare serum versus cream direction during concept planning
- Support internal product alignment before formulation development
- Accelerate OEM/ODM discussion with a clearer format direction
What Can Be Discussed
- Peptide positioning within a cream system
- Texture direction and product feel
- Supporting ingredient framework
- Documentation package for internal review
- Project customization for different market needs
Development Notes
Final formulation, compatibility, stability, claims language, and compliance requirements should be confirmed during the actual product development process.
Development Discussion Guide
Development Discussion Guide
Project Brief
Use this section to confirm target format, target market, and the desired firming care direction before moving deeper into OEM / ODM follow-up.
Technical Alignment
Review the key peptide, supporting file needs, and any sample or validation expectations that should be aligned for the next discussion step.
Customization Scope
Clarify whether the project needs formula adjustment, texture direction, packaging discussion, or staged development planning before scale-up.
FAQ
Frequently Asked Questions
Can you support sample planning and follow-up toward larger-scale production?
That can be discussed according to the project scope and current stage. For finished-product projects, it is helpful to first clarify the product direction, expected development path, and what kind of evaluation your team needs next.
Cosmetic Pro-Peptide Delivery & Flexible ISO 22716 ODM
Developing a mid-to-high-end skincare or scalp SKU with Palmitoyl Pentapeptide-4 Firming Cream Concept?
Compare neat raw actives, AHPX+ modified-chitosan delivery complex
(CN120248173A, +219% 8h skin permeation), bulk compounded
kg / liter semi-finished bases, and phased custom-packaged ODM at
Suzhou Xilin Technology Co., Ltd. (ISO 22716:2007 Cert. 27825-2025GPOC00009R000,
covering liquid & eye-care/cream scope): explore our Pro-Peptide Science & ODM Hub or Finished Skincare OEM / ODM Service.
Request Palmitoyl Pentapeptide-4 Firming Cream Concept Benchmark Sample, Bulk Base, or Phased ODM Quote
Share your target format (raw active by g/kg, bulk semi-finished base by kg/liter, or custom-packaged ODM), target active %, and destination market (EU PIF/CPSR, UK SCPN, US MoCRA, ANVISA).